Your browser doesn't support javascript.
loading
Transcriptional signature in microglia isolated from an Alzheimer's disease mouse model treated with scanning ultrasound.
Leinenga, Gerhard; Bodea, Liviu-Gabriel; Schröder, Jan; Sun, Giuzhi; Zhou, Yichen; Song, Jae; Grubman, Alexandra; Polo, Jose M; Götz, Jürgen.
Afiliação
  • Leinenga G; Clem Jones Centre for Ageing Dementia Research, Queensland Brain Institute, The University of Queensland Brisbane (St Lucia Campus) Queensland Australia.
  • Bodea LG; Clem Jones Centre for Ageing Dementia Research, Queensland Brain Institute, The University of Queensland Brisbane (St Lucia Campus) Queensland Australia.
  • Schröder J; Department of Anatomy & Developmental Biology and the Australian Regenerative Medicine Institute Monash University Melbourne Victoria Australia.
  • Sun G; Department of Anatomy & Developmental Biology and the Australian Regenerative Medicine Institute Monash University Melbourne Victoria Australia.
  • Zhou Y; Department of Anatomy & Developmental Biology and the Australian Regenerative Medicine Institute Monash University Melbourne Victoria Australia.
  • Song J; Clem Jones Centre for Ageing Dementia Research, Queensland Brain Institute, The University of Queensland Brisbane (St Lucia Campus) Queensland Australia.
  • Grubman A; Department of Anatomy & Developmental Biology and the Australian Regenerative Medicine Institute Monash University Melbourne Victoria Australia.
  • Polo JM; Department of Anatomy & Developmental Biology and the Australian Regenerative Medicine Institute Monash University Melbourne Victoria Australia.
  • Götz J; Clem Jones Centre for Ageing Dementia Research, Queensland Brain Institute, The University of Queensland Brisbane (St Lucia Campus) Queensland Australia.
Bioeng Transl Med ; 8(1): e10329, 2023 Jan.
Article em En | MEDLINE | ID: mdl-36684089
Transcranial scanning ultrasound combined with intravenously injected microbubbles (SUS+MB) has been shown to transiently open the blood-brain barrier and reduce the amyloid-ß (Aß) pathology in the APP23 mouse model of Alzheimer's disease (AD). This has been accomplished through the activation of microglial cells; however, their response to the SUS treatment is incompletely understood. Here, wild-type (WT) and APP23 mice were subjected to SUS+MB, using nonsonicated mice as sham controls. After 48 h, the APP23 mice were injected with methoxy-XO4 to label Aß aggregates, followed by microglial isolation into XO4+ and XO4- populations using flow cytometry. Both XO4+ and XO4- cells were subjected to RNA sequencing and transcriptome profiling. The analysis of the microglial cells revealed a clear segregation depending on genotype (AD model vs. WT mice) and Aß internalization (XO4+ vs. XO4- microglia), but interestingly, no differences were found between SUS+MB and sham in WT mice. Differential gene expression analysis in APP23 mice detected 278 genes that were significantly changed by SUS+MB in the XO4+ cells (248 up/30 down) and 242 in XO- cells (225 up/17 down). Pathway analysis highlighted differential expression of genes related to the phagosome pathway and marked upregulation of cell cycle-related transcripts in XO4+ and XO4- microglia isolated from SUS+MB-treated APP23 mice. Together, this highlights the complexity of the microglial response to transcranial ultrasound, with potential applications for the treatment of AD.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Bioeng Transl Med Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Bioeng Transl Med Ano de publicação: 2023 Tipo de documento: Article